Skip to main content
Log in

Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV

  • Published:
Genetica Aims and scope Submit manuscript

Abstract

Hemophilia-AIDS has been interpreted in terms of two hypotheses: the foreign-protein-AIDS hypothesis and the Human Immunodeficiency Virus (HIV)-AIDS hypothesis. The foreign-protein-AIDS hypothesis holds that proteins contaminating commercial clotting factor VIII cause immunosuppression. The foreign-protein hypothesis, but not the HIV hypothesis, correctly predicts seven characteristics of hemophilia-AIDS: 1) The increased life span of American hemophiliacs in the two decades before 1987, although 75% became infected by HIV —because factor VIII treatment, begun in the 1960s, extended their lives and simultaneously disseminated harmless HIV. After 1987 the life span of hemophiliacs appears to have decreased again, probably because of widespread treatment with the cytotoxic anti-HIV drug AZT. 2) The distinctly low, 1.3–2%, annual AIDS risk of hemophiliacs, compared to the higher 5–6% annual risk of intravenous drug users and male homosexual aphrodisiac drug users — because transfusion of foreign proteins is less immunosuppressive than recreational drug use. 3) The age bias of hemophilia-AIDS, i.e. that the annual AIDS risk increased 2-fold for each 10-year increase in age —because immunosuppression is a function of the lifetime dose of foreign proteins received from transfusions. 4) The restriction of hemophilia-AIDS to immunodeficiency diseases — because foreign proteins cannot cause non-immunodeficiency AIDS diseases, like Kaposi's sarcoma. 5) The absence of AIDS diseases above their normal background in sexual partners of hemophiliacs — because transfusion-mediated immunotoxicity is not contagious. 6) The occurrence of immunodeficiency in HIV-free hemophiliacs — because foreign proteins, not HIV, suppress their immune system. 7) Stabilization, even regeneration, of immunity of HIV-positive hemophiliacs by long-term treatment with pure factor VIII. This shows that neither HIV nor factor VIII plus HIV are immunosuppressive by themselves. Therefore, AIDS cannot be prevented by elimination of HIV from the blood supply and cannot be rationally treated with genotoxic antiviral drugs, like AZT. Instead, hemophilia-AIDS can be prevented and has even been reverted by treatment with pure factor VIII.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • AIDS-Hemophilia French Study Group, 1985. Immunologic and virologic status of multitransfused patients: Role of type and origin of blood products. Blood 66: 896–901.

    Google Scholar 

  • Aledort, L.M., 1988. Blood products and immune changes: impacts without HIV infection. Sem. Hematol. 25: 14–19.

    Google Scholar 

  • Anderson, R.M. & R.M. May, 1988. Epidemiological parameters of HIV transmission. Nature (London) 333: 514–519.

    Google Scholar 

  • Anonymous, 1984. The cause of AIDS? Lancet i: 1053–1054.

  • Antonaci, S., E. Jirillo, D. Stasi, V. De Mitrio, M.R. La Via & L. Bonomo, 1988. Immunoresponsiveness in hemophilia: Lymphocyte-and Phagocyte-mediated functions. Diagn. Clin. Immunol. 5: 318–325.

    PubMed  Google Scholar 

  • Aronson, D.L., 1983. Pneumonia deaths in haemophiliacs. Lancet ii: 1023.

    Google Scholar 

  • Associated Press, 1994. Red Cross knew of AIDS blood threat. San Francisco Chronicle, May, 16.

  • Auerbach, D.M., W.W. Darrow, H.W. Jaffe & J.W. Curran, 1984. Cluster of cases of the Acquired Immune Deficiency Syndrome patients linked by sexual contact. Am. J. Med. 76: 487–492.

    PubMed  Google Scholar 

  • Bagasra, O., S.P. Hauptman, H.W. Lischner, M. Sachs & R.J. Pomerantz, 1992. Detection of human immunodeficiency virus type 1 provirus in mononuclear cells by in situ polymerase chain reaction. N. Engl. J. Med. 326: 1385–1391.

    PubMed  Google Scholar 

  • Becherer, P.R., M.L. Smiley, T.J. Matthews, K.J. Weinhold, C.W. McMillan & G.C.I. White, 1990. Human immunodeficiency virus-1 disease progression in hemophiliacs. Am. J. Hematol. 34: 204–209.

    PubMed  Google Scholar 

  • Biggar, R.J. & the International Registry of Seroconverters, 1990. AIDS incubation in 1891 HIV seroconverters from different exposure groups. AIDS 4: 1059–1066.

    PubMed  Google Scholar 

  • Blattner, W.A., (1991). HIV epidemiology: past, present, and future. FASEB J. 5: 2340–2348.

    PubMed  Google Scholar 

  • Blattner, W.A., R.C. Gallo & H.M. Temin, 1988. HIV causes AIDS. Science 241: 514–515.

    PubMed  Google Scholar 

  • Booth, W., 1988. A rebel without a cause for AIDS. Science 239: 1485–1488.

    PubMed  Google Scholar 

  • Brettler, D.B., A.D. Forsberg, F. Brewster, J.L. Sullivan & P.H. Levine, 1986. Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate. Am. J. Med. 81: 607–611.

    PubMed  Google Scholar 

  • Brettler, D.B. & P.H. Levine, 1989. Factor concentrates for treatment of hemophilia: which one to choose? Blood 73: 2067–2073.

    PubMed  Google Scholar 

  • Cairns, J., 1978. Cancer: Science and Society. W.H. Freeman and Company, San Francisco.

    Google Scholar 

  • Carr, R., E. Edmond, R.J. Prescott, S.E. Veitch, J.F. Peutherer & C.M. Steel, 1984. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population. Lancet i: 1431–1434.

    Google Scholar 

  • Centers for Disease Control, 1982. Pneumocystis carinii pneumonia among persons with hemophilia A. Morbid. Mort. Weekly Report 31: 365–367.

    Google Scholar 

  • Centers for Disease Control (eds), 1986. Reports on AIDS published in the Morbidity and Mortality Weekly Report, June 1981 through February 1986.

  • Centers for Disease Control and Prevention, 1994.HIV/AIDS Surveillance Report, Year-end Edition 4: 1–33.

    Google Scholar 

  • U.S. Dept. of Health and Human Services, National Technical Information Service, Springfield, VA.

  • Centers for Disease Control, 1992a. HIV/AIDS Surveillance Report — January Issue.

  • Centers for Disease Control, 1992b. The second 100,000 cases of Acquired Immunodeficiency Syndrome — United States, June 1981-December 1991. Morbid. Mort. Weekly Report 41: 28–29.

    Google Scholar 

  • Centers for Disease Control, 1993. HIV/AIDS Surveillance; year-end edition. February: 1–23.

  • Centers for Disease Control and Prevention, 1992. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb. Mort. Weekly Rep. 41 (No. RR17) 1–19.

    Google Scholar 

  • Chorba, T.L., R.C. Holman, T.W. Strine, M.J. Clarke & B.L. Evatt, 1994. Changes in longevity and causes of death among persons with hemophilia A. Am. J. Hematol. 45: 112–121.

    PubMed  Google Scholar 

  • Cohen, J., 1993. Keystone's blunt message: 1 It's the virus, stupid'. Science 260: 292–293.

    PubMed  Google Scholar 

  • Curran, J.W., M.W. Morgan, A.M. Hardy, H.W. Jaffe, W.W. Darrow & W.R. Dowdle, 1985. The epidemiology of AIDS: current status and future prospects. Science 229: 1352–1357.

    PubMed  Google Scholar 

  • Darby, S.C., C.R. Rizza, R. Doll, R.J.D. Spooner, I.M. Stratton & B. Thakrar, 1989. Incidence of AIDS and excess mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centers in the United Kingdom. Br. Med. J. 298: 1064–1068.

    Google Scholar 

  • de Biasi, R., A. Rocino, E. Miraglia, L. Mastrullo & A.A. Quirino, 1991. The impact of a very high purity of factor VIII concentrate on the immune system of human immunodeficiency virus-infected hemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate. Blood 78: 1919–1922.

    PubMed  Google Scholar 

  • Detels, R., P.A. English, J.V. Giorgi, B.R. Visscher, J.L. Fahey, J.M.G. Taylor, J.P. Dudley, P. Nishanian, A. Munoz, J.P. Phair, B.F. Polk & C.R. Rinaldo, 1988. Patterns of CD4+ cell changes after HIV-1 infection indicate the existence of a codeterminant of AIDS. Journal of Acquired Immune Deficiency Syndromes 1: 390–395.

    PubMed  Google Scholar 

  • Dickson, D., 1994. Critic still lays blame for AIDS on lifestyle, not HIV. Nature (London) 369: 434.

    Google Scholar 

  • Duesberg, P.H., 1990. Quantification of human immunodeficiency virus in the blood. N. Engl. J. Med. 322: 1466.

    PubMed  Google Scholar 

  • Duesberg, P.H., 1991. AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease. Proc. Natl. Acad. Sci. USA 88: 1575–1579.

    PubMed  Google Scholar 

  • Duesberg, P.H., 1992a. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmacology & Therapeutics 55: 201–277.

    Google Scholar 

  • Duesberg, P.H., 1992b. HIV as target for zidovudine. Lancet 339: 551.

    Google Scholar 

  • Duesberg, P.H., 1992c. HIV, AIDS, and zidovudine. Lancet 339: 805–806.

    PubMed  Google Scholar 

  • Duesberg, P.H., 1993a. HIV and AIDS. Science 260: 1705.

    PubMed  Google Scholar 

  • Duesberg, P.H., 1993b. The HIV gap in national AIDS statistics. Biotechnology 11: 955–956.

    PubMed  Google Scholar 

  • Duesberg, P.H., 1994. Infectious AIDS—stretching the germ theory beyond its limits. Int. Arch. Allergy Immunol. 103: 131–142.

    PubMed  Google Scholar 

  • Evatt, B.L., R.B. Ramsey, D.N. Lawrence, L.D. Zyla & J.W. Curran, 1984. The acquired immunodeficiency syndrome in patients with hemophilia. Ann. Intern. Med. 100: 499–505.

    PubMed  Google Scholar 

  • Eyster, M.E. & M.E. Nau, 1978. Particulate material in antihemophiliac factor (AHF) concentrates. Transfusion September–October: 576–581.

    Google Scholar 

  • Eyster, M.E., D.A. Whitehurst, P.M. Catalano, C.W. McMillan, S.H. Goodnight, C.K. Kasper, J.C. Gill, L.M. Aledort, M.W. Hilgartner, P.H. Levine, J.R. Edson, W.E. Hathaway, J.M. Lusher, F.M. Gill, W.K. Poole & S.S. Shapiro. Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopenia. Blood 66: 1317–1320.

  • Fauci, A.S., 1993. CD4+ T-lymphocytopenia without HIV infection — no lights, no camera, just facts. N. Engl. J. Med. 328: 429–431.

    PubMed  Google Scholar 

  • Fields, B.N., 1994. AIDS: time to turn to basic science. Nature (London) 369: 95–96.

    Google Scholar 

  • Fischl, M.A., D.D. Richman, M.H. Grieco, M.S. Gottlieb, P.A. Volberding, O.L. Laskin, J.M. Leedon, J.E. Groopman, D. Mildvan, R.T. Schooley, G.G. Jackson, D.T. Durack, D. King & the AZT Collaborative Working Group, 1987. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317: 185–191.

    PubMed  Google Scholar 

  • Fletcher, M.A., J.W. Mosley, J. Hassett, G.F. Gjerset, J. Kaplan, J.W. Parker, E. Donegan, J.M. Lusher, H. Lee & Transfusion Safety Study Group, 1992. Effect of Age on Human Immunodeficiency Virus Type 1-Induced Changes in Lymphocyte Populations Among Persons with Congenital Clotting Disorders. Blood 80: 831–840.

    PubMed  Google Scholar 

  • Froebel, K.S., R. Madhok, C. Forbes, S.E. Lennie, G.D. Lowe & R.D. Sturrock, 1983. Immunological abnormalities in haemophilia: are they caused by American factor VIII concentrate? Br. Med. J. 287: 1091–1093.

    Google Scholar 

  • Gill, J.C., M.D. Menitove, P.R. Anderson, J.T. Casper, S.G. Devare, C. Wood, S. Adair, J. Casey, C. Scheffel & M.D. Montgomery, 1986. HTLV-III serology in hemophilia: Relationship with immunologic abnormalities. J. Pediatr. 108: 511–516.

    PubMed  Google Scholar 

  • Gjerset, G.F., M.C. Pike, J.W. Mosley, J. Hassett, M.A. Fletcher, E. Donegan, J.W. Parker, R.B. Counts, Y. Zhou, C.K. Kasper, E.A. Operskalski & The Transfusion Safety Study Group, 1994. Effect of Low- and Intermediate-Purity Clotting Factor Therapy on Progression of Human Immunodeficiency Virus Infection in Congenital Clotting Disorders. Blood 84: 1666–1671.

    PubMed  Google Scholar 

  • Goedert, J.J., C.M. Kessler, L.M. Aledort, R.J. Biggar, W.A. Andes, G.C. White II, J.E. Drummond, K. Vaidya, D.L. Mann, M.E. Eyster, M.V. Ragni, M.M. Lederman, A.R. Cohen, G.L. Bray, P.S. Rosenberg, R.M. Friedman, M.W. Hilgartner, W.A. Blattner, B. Kroner & M.H. Gail, 1989. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N. Engl. J. Med. 321: 1141–1148.

    PubMed  Google Scholar 

  • Goedert, J.J., A.R. Cohen, C.M. Kessler, S. Eichinger, S.V. Seremetis, C.S. Rabkin, F.J. Yellin, P.S. Rosenberg & L.M. Aledort, 1994. Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Lancet 344: 791–792.

    PubMed  Google Scholar 

  • Goldsmith, J.M., J. Deutsche, M. Tang & D. Green, 1991. CD4 Cells in HIV-1 Infected Hemophiliacs: Effect of Factor VIII Concentrates. Thromb. Haemost. 66: 415–419.

    PubMed  Google Scholar 

  • Gomperts, E.D., R. De Biasi & R. De Vreker, 1992. The Impact of Clotting Factor Concentrates on the Immune System in Individuals with Hemophilia. Transfus. Med. Rev. 6: 44–54.

    PubMed  Google Scholar 

  • Gordon, R.S., 1983. Factor VIII products and disordered immune regulation. Lancet i: 991.

    Google Scholar 

  • Hardy, A.M., J.R. Allen, W.M. Morgan & J.W. Curran, 1985. The incidence rate of acquired immunodeficiency syndrome in selected populations. J. Am. Med. Assoc. 253: 215–220.

    Google Scholar 

  • Hassett, J., G.F. Gjerset, J.W. Mosley, M.A. Fletcher, E. Donegan, J.W. Parker, R.B. Counts, L.M. Aledort, H. Lee, M.C. Pike & Transfusion Safety Study Group, 1993. Effect on Lymphocyte Subsets of Clotting Factor Therapy in Human Immunodeficiency Virus-1-Negative Congenital Clotting Disorders. Blood 82: 1351–1357.

    PubMed  Google Scholar 

  • Haverkos, H.W. & J.A. Dougherty, (eds), 1988. Health Hazards of Nitrite Inhalants. NIDA Research Monograph 83, US. Dept. Health & Human Services, Washington, DC.

    Google Scholar 

  • Haverkos, H.W., P.F. Pinsky, D.P. Drotman & D.J. Bregman, 1985. Disease manifestation among homosexual men with acquired immunodeficiency syndrome: a possible role of nitrites in Kaposi's sarcoma. J. Sex. Trans. Dis. 12: 203–208.

    Google Scholar 

  • Hilgartner, M.W., J.D. Buckley, E.A. Operskalski, M.C. Pike & J.W. Mosley, 1993. Purity of factor VIII concentrates and serial CD4 counts. Lancet 341: 1373–1374.

    PubMed  Google Scholar 

  • Hollan, S.R., G. Fuest, K. Nagy, A. Horvath, G. Krall, K. Verebelyi, E. Ujhelyi, L. Varga & V. Mayer, 1985. Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary. Immunol. Letters 11: 305–310.

    Google Scholar 

  • Hughes, M.D., D.S. Stein, H.M. Gundacker, F.T. Valentine, J.P. Phair & P.A. Volberding, 1994. Within-Subject Variation in CD4 Lymphocyte Count in Asymptomatic Human Immunodeficiency Virus Infection: Implications for Patient Monitoring. The Journal of Infectious Diseases 169: 28–36.

    PubMed  Google Scholar 

  • Institute of Medicine, 1988. Confronting AIDS—Update 1988. National Academy Press, Washington, DC.

    Google Scholar 

  • Institute of Medicine and National Academy of Sciences, 1986. Confronting AIDS. National Academy Press, Washington, DC.

    Google Scholar 

  • Jason, J., R.C. Holman, B.L. Evatt & the Hemophilia-AIDS Collaborative Study Group, 1990. Relationship of partially purified factor concentrates to immune tests and AIDS. Am. J. Hematol. 34: 262–269.

    PubMed  Google Scholar 

  • Jason, J.M., J.S. McDougal, G. Dixon, D.N. Lawrence, M.S. Kennedy, M. Hilgartner, L. Aledort & B.L. Evatt, 1986. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia. J. Am. Med. Assoc. 255: 212–215.

    Google Scholar 

  • Jin, Z., R.P. Cleveland & D.B. Kaufman, 1989. Immunodeficiency in patients with hemophilia: an underlying deficiency and lack of correlation with factor replacement therapy or exposure to human immunodeficiency virus. Allergy Clin. Immunol. 83: 165–170.

    Google Scholar 

  • Johnson, R.E., D.N. Lawrence, B.L. Evatt, D.J. Bregman, L.D. Zyla, J.W. Curran, L.M. Aledort, M.E. Eyster, A.P. Brownstein & C.J. Carman, 1985. Acquired immunodeficiency syndrome among patients attending hemophilia treatment centers and mortality experience of hemophiliacs in the United States. Am. J. Epidemiol. 121: 797–810.

    PubMed  Google Scholar 

  • Jones, C., 1994. AIDS: Words from the Front. SPIN, October: 7: 103–104.

    Google Scholar 

  • Jones, P., S. Proctor, A. Dickinson & S. George, 1983. Altered immunology in haemophilia. Lancet i: 120–121.

    Google Scholar 

  • Kessler, C.M., R.S. Schulof, A.L. Goldstein, P.H. Naylor, N.L. Luban, J.F. Kelleher & G.H. Reaman, 1983. Abnormal T-lymphocyte subpopulations associated with transfusions of blood-derived products. Lancet i: 991–992.

    Google Scholar 

  • Koerper, M.A., 1989. AIDS and Hemophilia. In: AIDS: Pathogenesis and Treatment, pp. 79–95, J.A. Levy (ed.) Marcel Dekker, Inc., New York.

    Google Scholar 

  • Kreiss, J.K., C.K. Kasper, J.L. Fahey, M. Weaver, B.R. Visscher, J.A. Steward & D.N. Lawrence, 1984. Nontransmission of T-cell subset abnormalities from hemophiliacs to their spouses. J. Am. Med. Assoc. 251: 1450–1454.

    Google Scholar 

  • Kreiss, J.K., L.W. Kitchen, H.E. Prince, C.K. Kasper, A.L. Goldstein, P.H. Naylor, O. Preble, J.A. Stewart & M. Essex, 1986. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Am. J. Med. 80: 345–350.

    PubMed  Google Scholar 

  • Lang, D.J., A.A.S. Kovacs, J.A. Zaia, G. Doelkin, J.C. Niland, L. Aledort, S.P. Azen, M.A. Fletcher, J. Gauderman, G.J. Gjerst, J. Lusher, E.A. Operskalski, J.W. Parker, C. Pegelow, G.N. Vyas, J.W. Mosley & the Transfusion Safety Group, 1989. Seroepidemiologic studies of cytomegalovirus and Eptsein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. J. AIDS 2: 540–549.

    Google Scholar 

  • Lauritsen, J. & H. Wilson, 1986. Death, Rush, Poppers and AIDS. Pagan Press, New York.

    Google Scholar 

  • Lawrence, D.N., J.M. Jason, R.C. Holman & J.J. Murphy, 1990. HIV transmission from hemophilic men to their heterosexual partners. In: Heterosexual Transmission of AIDS, pp. 35–53. N.J. Alexander, H.L. Gabelnick & Spieler, J.M. (eds.) Wiley-Liss, New York.

    Google Scholar 

  • Lee, C.A., A.N. Phillips, J. Elford, G. Janossy, Janossy, P., Griffiths & P. Kernoff, 1991. Progressio of HIV disease in a haemophiliac cohort followed for 11 years and the effect of treatmen. Br. Med. J. 303: 1093–1096.

    Google Scholar 

  • Lemp, G.F., S.F. Payne, G.W. Rutherford, N.A. Hessol, W. Winkelstein Jr., J.A. Wiley, A.R. Moss, R.E. Chaisson, R.T. Chen, D.W. Feigal, P.A. Thomas & Werdegar, D., 1990. Projections of AIDS morbidity and mortality in San Francisco. J. Am. Med. Assoc. 263: 1497–1501.

    Google Scholar 

  • Lenderking, W.R., R.D. Gelber, D.J. Cotton, B.F. Cole, A. Goldhirsch, P.A. Volberuding & M.A. Testa, 1994. Evaluation of the quality of life associated with Zidovudine treatment in asymptomatic Human Immunodeficiency Virus Infection. N. Engl. J. Med. 330: 738–743.

    PubMed  Google Scholar 

  • Leonhard, H.-W., 1992. Alles nurein Irrtum? neue praxis: Zeitschrift für Sozialarbeit, Sozialpädogogik und Sozialpolitik 22: 14–29.

    Google Scholar 

  • Lewis, A., 1994. Down the tabloid slope. New York Times, July, 4, Monday.

  • Ludlam, C.A., J. Tucker, C.M. Steel, R.S., Tedder, R. Cheingsong-Popov, R. Weiss, D.B.L. McClelland, I. Phillip & R.J. Prescott, 1985. Human T-lymphtropic virus type III (HTLV-III) infection in seronegative hemophiliacs after transfusion of factor VIII. Lancet ii: 233–236.

    Google Scholar 

  • Lui, K.-J., W.W. Darrow & G.W. Rutherford III, 1988. A modelbased estimate of the mean incubation period for AIDS in homosexual men. Science 240: 1333–1335.

    PubMed  Google Scholar 

  • Lundgren, J.D., A.N. Philips, C. Pedersen, N. Clumeck, J.M. Gatell, A.M. Johnson, B. Ledergerber, S. Vella & J.O. Nielsen, 1994. Comparison of long-term prognosis of patients with AIDS treated and not treated with Zidovudine. J. Am. Med. Assoc. 271: 1088–1092.

    Google Scholar 

  • Macilwain, C., 1994. AAAS criticized over AIDS sceptics' meeting. Nature (London) 369: 265.

    Google Scholar 

  • Madhok, R., A. Gracie, G.D.O. Lowe, A. Burnett, K. Froebel, E. Follett & C.D. Forbes, 1986. Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. Br. Med. J. 293: 978–980.

    Google Scholar 

  • Mahir, W.S., R.E. Millard, J.C. Booth & P.T. Flute, 1988. Functional studies of cell-mediated immunity in haemophilia and other bleeding disorders. Br. J. Haematol. 69: 367–370.

    PubMed  Google Scholar 

  • Mannucci, P.M., A. Gringeri, R. De Biasi, F. Baudo, M. Morfini & N. Ciavarella, 1992. Immune status of asymptomatic HIV-infected hemophiliacs: randomised, prospective, two-year comparison of treatment with a high-priority of an intermediate purity factor VIII concentrate. Thromb. Haemost. 67: 310–313.

    PubMed  Google Scholar 

  • Marmor, M., A.E. Friedman-Kien, L. Laubenstein, R.D. Byrum, D.C. William, S. D'Onofrio & N. Dubin, 1982. Risk factors for Kaposi's sarcoma in homosexual men. Lancet i: 1083–1087.

    Google Scholar 

  • Matheson, D.S., B.J. Green, M.J. Fritzler, M.-C. Poon, T.J. Bowen & D.I. Hoar, 1987. Humoral immune response in patients with hemophilia. Clin. Immunol Immunopathol. 4: 41–50.

    Google Scholar 

  • Mathur-Wagh, U., R.W. Enlow, I. Spigland, R.J. Winchester, H.S. Sacks, E. Rorat, S.R. Yancovitz, M.J. Klein, D.C. William & D. Mildwan, 1984. Longitudinal study of persistent generalized lyumphadenopathy in homosexual men: Relation to acquired immunodeficiency syndrom. Lancet i: 1033–1038.

    Google Scholar 

  • Mathur-Wagh, U., D. Mildvan & R.T. Senie, 1985. Follow-up of 4 1/2 years on homosexual men with generalized lymphadenopathy. N. Engl. J. Med. 313: 1542–1543.

    PubMed  Google Scholar 

  • Maynard, T., 1994. Factor concentrate is a co-factor. Aids News (Hemophilia Council of California) 8: 1.

    Google Scholar 

  • McGrady, G.A., J.M. Jason & B.L. Evatt, 1987. The course of the epidemic of acquired immunodeficiency syndrome in the United States hemophilia population. Am. J. Epidemiol. 126: 25–80.

    PubMed  Google Scholar 

  • Menitove, J.E., R.H. Aster, J.T. Casper, S.J. Lauer, J.L. Gottschall, J.E. Williams, J.C. Gill, D.V. Wheeler, V. Piaskowski, P. Kirchner & R.R. Montgomery, 1983. T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N. Engl. J. Med. 308: 83–86.

    PubMed  Google Scholar 

  • Merrian-Webster (eds), 1965 Webster's Third International Dictionary. G. & C. Merriam Co., Springfield, MA.

    Google Scholar 

  • Moffat, E.H. & Bloom, A.L., 1985. HTLV-III antibody status and immunological abnormalities in haemophiliac patients. Lancet i: 935.

    Google Scholar 

  • Morgan, M., J.W. Curran & R.L. Berkelman, 1990. The future course of AIDS in the United States. J. Am. Med. Assoc. 263: 1539–1540.

    Google Scholar 

  • Newell, G.R., P.W.A. Mansell, M.B. Wilson, H.K. Lynch, M.R. Spitz & E.M. Hersh, 1985. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Preventive Med. 14: 81–91.

    Google Scholar 

  • Mussbaum, B., 1990. Good Intentions: How Big Business, Politics, and Medicine are Corrupting the Fight Against AIDS. Atlantic Monthly Press, New York.

    Google Scholar 

  • Oddone, E.Z., P. Cowper, J.D. Hamilton, D.B. Matchar, P. Hartigan, G. Samsa, M. Simberkoff & J.R. Feussner, 1993. Costeffectiveness analysis of early zidovudine treatment of HIV infected patients. Br. Med. J. 307: 1322–1325.

    Google Scholar 

  • Oppenheimer, G.M. 1992. Causes, cases, and cohorts: The role of epidemiology in the historical construction of AIDS. In: AIDS: The Making of a Chronic Disease, pp. 49–83, E. Fee & D.M. Fox, (eds.) University of California Press, Berkeley.

    Google Scholar 

  • Papadopulos-Eleopulos, E., V.F. Turner, J.M. Papdimitriou & D. Causer, 1994. Factor VIII, HIV and AIDS in haemophiliacs: an analysis of their relationship. Genetica in press.

  • Philips, A.N., C.A. Sabin, J. Elford, M. Bofill, V. Emery, P.D. Griffiths, G. Janossy & C.A. Lee, 1994a. Viral burden in HIV infection. Nature (London) 367: 124.

    Google Scholar 

  • Phillips, A.N., C.A. Sabin, J. Elford, M. Bofill, G. Janossy & C.A. Lee, 1994b. Use of CD4 lymphocyte count to predict long term survival free of AIDS after HIV infection Br. Med. J. 309: 309–313.

    Google Scholar 

  • Piatak, M., L.C. Saag, S.C. Yang, S.J. Clark, J.C. Kappes, K.-C. Luk, B.H. Hahn, G.M. Shaw & J.D. Lifson, 1993. High levelds of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259: 1749–1754.

    PubMed  Google Scholar 

  • Pollack, S., D. Atias, G. Yoffe, R. Katz, Y. Shechter & I. Tatarsky, 1985. Impaired immune function in hemophilia patients treated exclusively with cryoprecipitate: relation to duration of treatment. Am. J. Hematol 20: 1–6.

    PubMed  Google Scholar 

  • Prince, H., 1992. The significance of T lymphocytes in transfusion medicine. Transfus. Med. Rev. 16: 32–43.

    Google Scholar 

  • Richman, D.D., M.A. Fischl, M.H. Grieco, M.S. Gottlieb, P.A. Volberding, O.L. Laskin, J.M. Leedom, J.E. Groopman, D. Mildvan, M.S. Hirsch, G.G. Jackson, D.T. Durack, S. Nusinoff-Lehrman & the AZT Collaborative Working Group 1987. The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med. 317: 192–197.

    PubMed  Google Scholar 

  • Schulman, S., 1991. Effects of factor VIII concentrates on the immune system in hemophilic patients. Annals of Hematology 63: 145–151.

    PubMed  Google Scholar 

  • Schwartlaender, B., O. Hamouda, M.A. Koch, W. Kiehl & C. Baars, 1992. AIDS/HIV 1991, AZ Hefte.

  • Schwarz, H.P., M. Kunschak, W. Engl & J. Eibl, 1994. High-purity Factor Concentrates in Prevention of AIDS. Lancet 343: 478–479.

    Google Scholar 

  • Seligmann, M., D.A. Warrell, J.-P. Aboulker, C., Carbon, J.H. Darbyshire, J. Dormont, E. Eschwege, D.J. Girling, D.R. James, J.-P. Levy, P.T.A. Peto, D. Schwarz, A.B. Stone, I.V.D. Weller, R. Withnall, K. Gelmon, E. Lafon, A.M. Swart, V.R. Aber, A.G. Babiker, S. Lhoro, A.J. Nunn & M. Vray, 1994. Concorde: MCR/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 343: 871–881.

    PubMed  Google Scholar 

  • Selik, R.M., E.T. Starcher & J.W. Curran, 1987. Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends. AIDS 1: 175–182.

    PubMed  Google Scholar 

  • Seremetis, S.V., L.M. Aledort, G.E. Bergman, R. Bona, G. Bray, D. Brettler, M.E. Eyster, C. Kessler, T.-S. Lau, J. Lusher & F. Rickles, 1993. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptomfree HIV-seropositive haemophiliacs: effects on immune status. Lancet 342: 700–703.

    PubMed  Google Scholar 

  • Sharp, R.A., S.M. Morley, J.S. Beck & G.E.D. Urquhart, 1987. Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV). J. Clin. Pathol 40: 849–852.

    PubMed  Google Scholar 

  • Sheppard, H.W., M.S. Ascher & J.F. Krowka, 1993. Viral burden and HIV disease. Nature (London) 364: 291–292.

    Google Scholar 

  • Shilts, R., 1985. And the Band Played On. St. Martin's Press, New York.

    Google Scholar 

  • Simmonds, P., P. Balfe, J.F. Peutherer, C.A. Ludlam, J.P. Bishop & A.J. Leigh-Brown, 1990. Human immunodeficiency virusinfected individuals contain provirus in small numbers of peripheral mononuclear cells at low copy numbers. J. Virol. 64: 864–872.

    PubMed  Google Scholar 

  • Simmonds, P., D. Beatson, R.J.G. Cuthbert, H. Watson, B. Reynolds, J.F. Peutherer, J.V. Parry, C.A. Ludlam & C.M. Steel, 1991. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338: 1159–1163.

    PubMed  Google Scholar 

  • Smith, D.K., J.J. Neal, S.D. Holmberg & Centers for Disease Control Idiopathic CD4+T-lymphocytopenia Task Force, 1993. Unexplained opportunistic infections and CD4+T-lymphocytopenia without HIV infection. N. Engl. J. Med. 328: 373–379.

    PubMed  Google Scholar 

  • Stehr-Green, J.K., R.C. Holman, J.M. Jason & B.L. Evatt, 1988. Hemophilia-associated AIDS in the United States, 1981 to September 1987. Am. J. Public Health 78: 439–442.

    PubMed  Google Scholar 

  • Stehr-Green, J.K., J.M. Jason, B.L. Evatt & the Hemophilia-Associated AIDS Study Group 1989. Geographic variability of hemophilia-associated AIDS in the United States: effect of population characteristics. Am. J. Hematol. 32: 178–183.

    PubMed  Google Scholar 

  • Sullivan, J.L., F.E. Brewster, D.B. Brettler, A.D. Forsberg, S.H. Cheeseman, K.S. Byron, S.M. Baker, D.L. Willitts, R.A. Lew & P.H. Levine, 1986. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J. Pediatr. 108: 504–510.

    PubMed  Google Scholar 

  • Thomas Jr., C.A., K.B. Mullis & P.E. Johnson, 1994. What causes AIDS? Reason 26, June: 18–23.

    Google Scholar 

  • Tokars, J.I., R. Marcus, D.H. Culver, C.A. Schable, P.S. McKibben, C.I. Bandea and D.M. Bell, 1993. Surveillance of HIV Infection and Zidovudine Use among Health Care Workers after Occupational Exposure to HIV-infected Blood. Ann. Intern. Med. 118: 913–919.

    PubMed  Google Scholar 

  • Tsoukas, C., F. Gervais, J. Shuster, P. Gold, M. O'Shaughnessy & M. Robert-Guroff, 1984. Association of HTLIV-III antibodies and cellular immune status of hemophiliacs. N. Engl. J. Med. 31: 1514–1515.

    Google Scholar 

  • Volberding, P.A., S.W. Lagakos, M.A. Koch, C. Pettinelli, M.W. Myers, D.K. Booth, H.H. Balfour Jr., R.C. Reichman, J.A. Bartlett, M.S. Hirsch, R.L. Murphy, W.D. Hardy, R. Soeiro, M.A. Fischl, J.G. Bartlett, T.C., Merigan, N.E. Hyslop, D.D. Richman, F.T. Valentine, L. Corey & the AIDS Clinical Trial Group of the National Institute of Allergy and Infectious Disease, 1990. Zidovudine in asymptomatic human immunodeficiency virus infection: A controlled trial in persons with fewer than 500 CD4-positive cells percubic millimeter. N. Engl. J. Med. 322: 941–949.

    PubMed  Google Scholar 

  • Weiss, R., 1991. Provenance of HIV strains. Nature (London) 349: 374.

    Google Scholar 

  • Weiss, R. & Jaffe, H., 1990. Duesberg, HIV and AIDS. Nature (London) 345: 659–660.

    Google Scholar 

  • Weiss, R.A., 1993. How does HIV cause AIDS? Science 260: 1273–1279.

    PubMed  Google Scholar 

  • Wells, J., 1993. We have to question the so-called ‘facts’. Capital Gay, August 20th: 14–15.

    Google Scholar 

  • World Health Organization, 1992a. Acquired Immunodeficiency Syndrome (AIDS)—Data as of 1 January 1992. World Health Organization, Geneva.

    Google Scholar 

  • World Health Organization, 1992b. WHO-Report No. 32: AIDS Surveillance in Europe (Situation by 31 st December 1991). Worl Health Organization, Geneva.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Duesberg, P.H. Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV. Genetica 95, 51–70 (1995). https://doi.org/10.1007/BF01435001

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01435001

Keywords

Navigation